Stockholders' Equity (Details) |
3 Months Ended |
|---|---|
|
Nov. 30, 2019
USD ($)
$ / shares
| |
| Warrants outstanding | $ | $ 107,416 |
| Weighted average life of outstanding warrants in years | 4 years |
| Exercise price | $ / shares | |
| March 2019 Notes Warrants [Member] | |
| Warrants outstanding | $ | $ 74,390 |
| Weighted average life of outstanding warrants in years | 4 years 3 months 19 days |
| Exercise price | $ / shares | $ 70.00 |
| June 2018 Notes Warrants [Member] | |
| Warrants outstanding | $ | $ 30,526 |
| Weighted average life of outstanding warrants in years | 3 years 6 months |
| Exercise price | $ / shares | $ 70.00 |
| 2017 PIPE Warrants [Member] | |
| Warrants outstanding | $ | $ 2,500 |
| Weighted average life of outstanding warrants in years | 2 years 7 months 6 days |
| Exercise price | $ / shares | $ 276.00 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|